Antibodies
Login
Search   
LEAF™ Purified anti-mouse IL-17A Antibody
LEAF™ Purified anti-mouse IL-17A Antibody
506905 50 µg ¥19,000     
506906 500 µg ¥56,000     
506923 1 mg ¥104,000     

Product Details

Clone: TC11-18H10.1
Isotype: Rat IgG1, κ
Isotype Control:LEAF™ Purified Rat IgG1, κ Isotype Ctrl
Reactivity: Mouse
Immunogen: E. coli-expressed, recombinant mouse IL-17A
Formulation: Phosphate-buffered solution, pH 7.2, containing no preservative. 0.2 μm filter sterilized. Endotoxin level is < 0.1 EU/μg of the protein (< 0.01 ng/μg of the protein) as determined by the LAL test.
Preparation: The LEAF™ (Low Endotoxin, Azide-Free) IL-17A antibody was Purified by affinity chromatography.
Concentration: 1.0 mg/ml
Storage & Handling: The IL-17A antibody solution should be stored undiluted at 4 °C. This LEAF™ solution contains no preservative; handle under aseptic conditions.
Application:

ELISA Capture, ELISPOT Capture, ICFC - Quality tested
Neut, FC, WB - Reported in the literature
CyTOF® - Validated

Recommended Usage:

Each lot of this IL-17A antibody is quality control tested by ELISA assay. For ELISA applications, a concentration range of 2-6 µg/ml is recommended. To obtain a linear standard curve, serial dilutions of IL-17 recombinant protein ranging from 4000 to 30 pg/ml are recommended for each ELISA plate. It is recommended that the reagent be titrated for optimal performance for each application.

COA:
Enter Lot#:   
Application
Notes:

ELISA Capture3,4 and ELISPOT Capture5: The purified TC11-18H10.1 antibody is useful as the capture antibody in a sandwich ELISA, when used in conjunction with the biotinylated TC11-8H4 antibody (Cat. No. 507002) as the detecting antibody and recombinant mouse IL-17 (Cat. No. 564101) as the standard.
Flow Cytometry2-4,7,8,11,12: The fluorochrome-labeled TC11-18H10.1 antibody is useful for intracellular immunofluorescent staining and flow cytometric analysis to identify IL-17 -producing cells within mixed cell populations. View intracellular cytokine staining protocol
Neutralization6,9: The LEAF™ purified antibody (Endotoxin <0.1 EU/μg, Azide-Free, 0.2 μm sterile-filtered) is recommended for neutralization of mouse IL-17 bioactivity in vivo and in vitro (Cat. No. 506906).
Additional reported applications (for the relevant formats) include: Western blotting.

Application
References:

1. Kennedy J, et al. 1996. J. Interferon Cytokine Res. 16:611.
2. Schubert D, et al. 2004. J. Immunol. 172:4503. (FC)
3. Infante-Duarte C, et al. 2000. J. Immunol. 165:6107. (FC, ELISA Capture)
4. Harrington LE, et al. 2005. Nature Immunol. doi:10.1038/ni1254. (FC, ELISA Capture)
5. Nekrasova T, et al. 2005. J. Immunol. 175:2734. (ELISPOT Capture)
6. Yen D, et al. 2006. J. Clin. Invest. 116:1310. (Neut)
7. Ehirchiou D, et al. 2007. J. Exp. Med. 204:1519. (FC)
8. Kang SG, et al. 2007. J. Immunol. 179:3724. (FC)
9. Smith E, et al. 2008. J. Immunol. 181:1357. (Neut) PubMed
10. Neufert C, et al. 2007. Eur. J. Immunol. 37:1809. PubMed
11. Wang C, et al. 2009. Mucosal Immunol 2:173. (FC) PubMed
12. Cui Y, et al. 2009. Invest. Ophth. Vis. Sci. 50:5811. (FC) PubMed
13. Kivisäkk P, et al. 2009. Ann. Neurol. 65:457. PubMed
14. Cooney LA, et al. 2011. J. Immunol. 187:4440. PubMed




Compare all formats



Description:

IL-17, also known as CTLA-8, is a T cell-expressed pleiotropic cytokine that exhibits a high degree of homology to a protein encoded by the ORF13 gene of herpes virus Saimiri. Recent study has shown that IL-17 is produced by Th cells (Th17) that are distinct from the traditional Th1- and Th2-cell subsets. IL-23 plays an important role in triggering IL-17 production. Both recombinant and natural IL-17 have been shown to exist as disulfide linked homodimers. IL-17 exhibits multiple biological activities on a variety of cells including: the induction of IL-6 and IL-8 production in fibroblasts, activation of NF-κB, and costimulation of T cell proliferation. IL-17 is an essential inflammatory mediator in the development of autoimmune diseases. Neutralization of IL-17 with monoclonal antibody is able to ameliorate the disease course.

Other Names: Interleukin-17, Cytotoxic T lymphocyte-associated antigen 8 (CTLA-8)
Structure: Cytokine; dimer; 15 kD (Mammalian)
Cellular Sources: CD4+ memory T cells
Cellular Targets: Fibroblasts, epithelial and endothelial cells, stromal cells
Receptors: IL-17R (CD217)
Bioactivity/Activities: Secretion of IL-6, IL-8, G-CSF, prostaglandin E2 by epithelial, endothelial or fibroblastic cells; stimulates cell migration, cord formation, and IL-6 secretion by stromal cells
Antigen
References:

1. Fitzgerald K, et al. Eds. 2001. The Cytokine FactsBook. Academic Press San Diego.
2. Numasaki M, et al. 2002. Blood 101:2620.
3. Fossiez F, et al. 1996. J. Exp. Med. 183:2593.
4. Yao Z, et al. 1997. Cytokine 9:794.
5. Dong C. 2006. Nat. Rev. Immunol. 6:329.
6. Hofstetter HH, et al. 2005 Cell. Immunol. 237:123.

GeneID: 16171
Latest Publications: View the latest IL-17A articles on HighwirePress.com
UniProt: View information about IL-17A on UniProt.org
Keywords: LEAF™ Purified anti-mouse IL-17A, TC11-18H10.1, LEAF™, Interleukin-17, Cytotoxic T lymphocyte-associated antigen 8 (CTLA-8), Mouse, Immunology, Antibodies
Related Products

DescriptionCloneApplications
LEAF™ Purified Rat IgG1, κ Isotype CtrlRTK2071FC, ICFC, WB, IP, ICC, IF, IHC, FA

*These products may be covered by one or more Limited Use Label Licenses (see the BioLegend Catalog or our website, www.biolegend.com/terms). BioLegend products may not be transferred to third parties, resold, modified for resale, or used to manufacture commercial products or to provide a service to third parties without written approval of BioLegend. By use of these products you accept the terms and conditions of all applicable Limited Use Label Licenses. Unless otherwise indicated, these products are for research use only and are not intended for human or animal diagnostic, therapeutic or commercial use.
x
Compare Data Across All Formats
This data display is provided for general comparisons between formats. Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors. If you need assistance with selecting the best format contact our expert technical support team.

  • PE anti-mouse IL-17A
    PMA/ionomycin-stimulated (5 hours) Th17 polarized

    PMA/ionomycin-stimulated (5 hours) Th17 polarized C57BL/6 mouse CD4+ T cells surface stained with CD4 (GK1.5) APC, then intracellularly stained with TC11-18H10.1 PE

    PMA (20 ng/ml) + ionomycin

    PMA (20 ng/ml) + ionomycin (1 µg/ml) -stimulated (6 hours + monensin, 2 µM) mouse thymoma cell line EL-4 intracellularly stained with TC11-18H10.1 PE

  • Purified anti-mouse IL-17A




  • LEAF™ Purified anti-mouse IL-17A




  • FITC anti-mouse IL-17A
    PMA (20 ng/ml) + ionomycin

    PMA (20 ng/ml) + ionomycin (1 µg/ml) -stimulated (6 hours + monensin, 2 µM) mouse thymoma cell line EL-4 intracellularly stained with TC11-18H10.1 FITC

  • Alexa Fluor® 488 anti-mouse IL-17A
    PMA (20 ng/ml) + ionomycin

    PMA (20 ng/ml) + ionomycin (1 µg/ml) -stimulated (6 hours + monensin, 2 µM) mouse thymoma cell line EL-4 intracellularly stained with TC11-18H10.1 Alexa Fluor® 488

  • Alexa Fluor® 647 anti-mouse IL-17A
    PMA/ionomycin-stimulated (5 hours) Th17 polarized

    PMA/ionomycin-stimulated (5 hours) Th17 polarized C57BL/6 mouse CD4+ T cells surface stained with CD4 (GK1.5) PE, then intracellularly stained with TC11-18H10.1 Alexa Fluor® 647

    PMA (20 ng/ml) + ionomycin

    PMA (20 ng/ml) + ionomycin (1 µg/ml) -stimulated (6 hours + monensin, 2 µM) mouse thymoma cell line EL-4 intracellularly stained with TC11-18H10.1 Alexa Fluor® 647

  • Alexa Fluor® 700 anti-mouse IL-17A
    6 hours PMA (20 ng/ml)

    6 hours PMA (20 ng/ml) + ionomycin (1 µg/ml) -stimulated mouse thymoma cell line EL-4 (in the presence of monensin) were intracellularly stained with IL-17 (clone TC11-18H10.1) Alexa Fluor® 700 (filled histogram) or rat IgG1, κ Alexa Fluor® 700 isotype control (open histogram).

  • APC anti-mouse IL-17A
    PMA (20 ng/ml) + ionomycin

    PMA (20 ng/ml) + ionomycin (1 µg/ml) -stimulated (6 hours + monensin, 2 µM) mouse thymoma cell line EL-4 intracellularly stained with TC11-18H10.1 APC

  • Pacific Blue™ anti-mouse IL-17A
    PMA (20 ng/ml) + ionomycin

    PMA (20 ng/ml) + ionomycin (1 µg/ml) -stimulated (6 hours + monensin, 2 µM) mouse thymoma cell line EL-4 intracellularly stained with TC11-18H10.1 Pacific Blue&trade

  • PerCP/Cy5.5 anti-mouse IL-17A
    PMA (20 ng/ml) + ionomycin

    PMA (20 ng/ml) + ionomycin (1 µg/ml) -stimulated (6 hours + monensin, 2 µM) mouse thymoma cell line EL-4 intracellularly stained with TC11-18H10.1 PerCP/Cy5.5

  • PE/Cy7 anti-mouse IL-17A
    PMA (20 ng/ml) + ionomycin

    PMA (20 ng/ml) + ionomycin (1 µg/ml) -stimulated (6 hours + monensin, 2 µM) mouse thymoma cell line EL-4 intracellularly stained with TC11-18H10.1 PE/Cy7

  • Brilliant Violet 421™ anti-mouse IL-17A
    Th17-polarized C57BL/6 mouse CD4+ lymphocytes

    Th17-polarized C57BL/6 mouse CD4+ lymphocytes were stimulated with PMA + Ionomycin for 6 hours in the presence of monensin, stained with CD4 FITC, fixed, permeabilized, and then stained with IL-17A (clone TC11-18H10.1) Brilliant Violet 421™ (top) or rat IgG1, κ Brilliant Violet 421™ isotype control (bottom).





  • Brilliant Violet 650™ anti-mouse IL-17A
    Th17-polarized C57BL/6 mouse CD4+ lymphocytes

    Th17-polarized C57BL/6 mouse CD4+ lymphocytes were stimulated with PMA + Ionomycin for 6 hours (in the presence of monensin), stained with CD4 FITC, fixed, permeabilized, and then stained with IL-17A (clone TC11-18H10.1) Brilliant Violet 650™.

x
Copyright © 2012 BioLegend, Inc. All rights reserved.